Researcher.Life Logo

Molecular and Clinical Oncology : Impact Factor & More

eISSN: 2049-9469pISSN: 2049-9450

Key Metrics

CiteScore
1.6
H-Index
16
SJR
Q3Oncology
SNIP
0.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Molecular and Clinical Oncology

Molecular and Clinical Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPANDIDOS PUBL LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2013
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Molecular and Clinical Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Molecular and Clinical Oncology

Research advances in the role of circulating microorganisms in gastrointestinal tumors (Review).
  • 1 Jun 2026
  • Molecular and clinical oncology
Differences in the clinical significance of CA125 for detecting progression among histological subtypes of epithelial ovarian carcinoma.
  • 1 Jun 2026
  • Molecular and clinical oncology
Presence of tuft cells expressing haematopoietic prostaglandin D synthase in intraductal papillary mucinous neoplasms of the pancreas
  • 6 May 2026
  • Molecular and Clinical Oncology
Urinary metabolomic signatures associated with early adverse events during volumetric modulated arc therapy for prostate cancer: A secondary analysis of a public dataset
  • 4 May 2026
  • Molecular and Clinical Oncology
Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer.
  • 1 May 2026
  • Molecular and clinical oncology
Crosstalk between immune and programmed cell death and their application in colorectal cancer risk stratification.
  • 21 Apr 2026
  • Molecular and clinical oncology
Research advances in the role of circulating microorganisms in gastrointestinal tumors (Review).
  • 1 Jun 2026
  • Molecular and clinical oncology
Differences in the clinical significance of CA125 for detecting progression among histological subtypes of epithelial ovarian carcinoma.
  • 1 Jun 2026
  • Molecular and clinical oncology
Presence of tuft cells expressing haematopoietic prostaglandin D synthase in intraductal papillary mucinous neoplasms of the pancreas
  • 6 May 2026
  • Molecular and Clinical Oncology
Urinary metabolomic signatures associated with early adverse events during volumetric modulated arc therapy for prostate cancer: A secondary analysis of a public dataset
  • 4 May 2026
  • Molecular and Clinical Oncology
Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer.
  • 1 May 2026
  • Molecular and clinical oncology
Crosstalk between immune and programmed cell death and their application in colorectal cancer risk stratification.
  • 21 Apr 2026
  • Molecular and clinical oncology

FAQs on Molecular and Clinical Oncology